 | • レポートコード：MRC2Q12-19331 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、咽頭炎治療薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 咽頭炎治療薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 咽頭炎治療薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 咽頭炎治療薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの咽頭炎治療薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の咽頭炎治療薬の売上および2028年までの予測に焦点を当てています。 咽頭炎治療薬のグローバル主要企業には、Genentech Inc、Adamas Pharmaceutical Inc、PLIVA HRVATSKA d.o.o、Pfizer Inc、Valeant Pharmaceuticals International, Inc、Mylan N.V、GSK group of companies、Teva Pharmaceutical Industries Ltd、AbbVie Inc、Viatris Inc. (Mylan)、GlaxoSmithKline plc、Abbott Laboratories、Amgen Inc、Sanofi-aventis Groupe、Purdue Pharma L.Pなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 咽頭炎治療薬市場は、タイプとアプリケーションによって区分されます。世界の咽頭炎治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、カプセル、スプレー、溶液、その他 【アプリケーション別セグメント】 病院薬局、小売店薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 咽頭炎治療薬製品概要 - タイプ別市場（錠剤、カプセル、スプレー、溶液、その他） - アプリケーション別市場（病院薬局、小売店薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の咽頭炎治療薬販売量予測2017-2028 - 世界の咽頭炎治療薬売上予測2017-2028 - 咽頭炎治療薬の地域別販売量 - 咽頭炎治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別咽頭炎治療薬販売量 - 主要メーカー別咽頭炎治療薬売上 - 主要メーカー別咽頭炎治療薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、カプセル、スプレー、溶液、その他） - 咽頭炎治療薬のタイプ別販売量 - 咽頭炎治療薬のタイプ別売上 - 咽頭炎治療薬のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、オンライン薬局） - 咽頭炎治療薬のアプリケーション別販売量 - 咽頭炎治療薬のアプリケーション別売上 - 咽頭炎治療薬のアプリケーション別価格 ・北米市場 - 北米の咽頭炎治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の咽頭炎治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの咽頭炎治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の咽頭炎治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の咽頭炎治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の咽頭炎治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の咽頭炎治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の咽頭炎治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの咽頭炎治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の咽頭炎治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Genentech Inc、Adamas Pharmaceutical Inc、PLIVA HRVATSKA d.o.o、Pfizer Inc、Valeant Pharmaceuticals International, Inc、Mylan N.V、GSK group of companies、Teva Pharmaceutical Industries Ltd、AbbVie Inc、Viatris Inc. (Mylan)、GlaxoSmithKline plc、Abbott Laboratories、Amgen Inc、Sanofi-aventis Groupe、Purdue Pharma L.P ・産業チェーン及び販売チャネル分析 - 咽頭炎治療薬の産業チェーン分析 - 咽頭炎治療薬の原材料 - 咽頭炎治療薬の生産プロセス - 咽頭炎治療薬の販売及びマーケティング - 咽頭炎治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 咽頭炎治療薬の産業動向 - 咽頭炎治療薬のマーケットドライバー - 咽頭炎治療薬の課題 - 咽頭炎治療薬の阻害要因 ・主な調査結果 |
Pharyngitis is a clinical disorder that involves inflammation in the pharynx i.e. the back of the throat. A painful throat is referred to as pharyngitis. Itching and trouble swallowing are other symptoms of pharyngitis. Pharyngitis is caused by a variety of bacterial and viral agents, the most common of which are measles, adenovirus, high cough, and streptococcus. A viral infection, e.g. the common cold, influenza, or mononucleosis, is the most prevalent cause of pharyngitis.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Pharyngitis Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Pharyngitis Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Pharyngitis Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Pharyngitis Drug include Genentech Inc, Adamas Pharmaceutical Inc, PLIVA HRVATSKA d.o.o, Pfizer Inc, Valeant Pharmaceuticals International, Inc, Mylan N.V, GSK group of companies, Teva Pharmaceutical Industries Ltd and AbbVie Inc, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pharyngitis Drug manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Pharyngitis Drug market. Further, it explains the major drivers and regional dynamics of the global Pharyngitis Drug market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Genentech Inc
Adamas Pharmaceutical Inc
PLIVA HRVATSKA d.o.o
Pfizer Inc
Valeant Pharmaceuticals International, Inc
Mylan N.V
GSK group of companies
Teva Pharmaceutical Industries Ltd
AbbVie Inc
Viatris Inc. (Mylan)
GlaxoSmithKline plc
Abbott Laboratories
Amgen Inc
Sanofi-aventis Groupe
Purdue Pharma L.P
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Pharyngitis Drug Segment by Type
Tablet
Capsule
Spray
Solution
Other
Pharyngitis Drug Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pharyngitis Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Pharyngitis Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Pharyngitis Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pharyngitis Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharyngitis Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Pharyngitis Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Pharyngitis Drug sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Genentech Inc, Adamas Pharmaceutical Inc, PLIVA HRVATSKA d.o.o, Pfizer Inc, Valeant Pharmaceuticals International, Inc, Mylan N.V, GSK group of companies, Teva Pharmaceutical Industries Ltd and AbbVie Inc, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pharyngitis Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pharyngitis Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharyngitis Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Pharyngitis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Pharyngitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Spray
1.2.5 Solution
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pharyngitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pharyngitis Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Pharyngitis Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Pharyngitis Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pharyngitis Drug Sales by Region
2.4.1 Global Pharyngitis Drug Sales by Region (2017-2022)
2.4.2 Global Sales Pharyngitis Drug by Region (2023-2028)
2.5 Global Pharyngitis Drug Revenue by Region
2.5.1 Global Pharyngitis Drug Revenue by Region (2017-2022)
2.5.2 Global Pharyngitis Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pharyngitis Drug Sales by Manufacturers
3.1.1 Global Top Pharyngitis Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Pharyngitis Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharyngitis Drug in 2021
3.2 Global Pharyngitis Drug Revenue by Manufacturers
3.2.1 Global Pharyngitis Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Pharyngitis Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pharyngitis Drug Revenue in 2021
3.3 Global Pharyngitis Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pharyngitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pharyngitis Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharyngitis Drug Sales by Type
4.1.1 Global Pharyngitis Drug Historical Sales by Type (2017-2022)
4.1.2 Global Pharyngitis Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Pharyngitis Drug Sales Market Share by Type (2017-2028)
4.2 Global Pharyngitis Drug Revenue by Type
4.2.1 Global Pharyngitis Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Pharyngitis Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pharyngitis Drug Revenue Market Share by Type (2017-2028)
4.3 Global Pharyngitis Drug Price by Type
4.3.1 Global Pharyngitis Drug Price by Type (2017-2022)
4.3.2 Global Pharyngitis Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pharyngitis Drug Sales by Application
5.1.1 Global Pharyngitis Drug Historical Sales by Application (2017-2022)
5.1.2 Global Pharyngitis Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Pharyngitis Drug Sales Market Share by Application (2017-2028)
5.2 Global Pharyngitis Drug Revenue by Application
5.2.1 Global Pharyngitis Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Pharyngitis Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pharyngitis Drug Revenue Market Share by Application (2017-2028)
5.3 Global Pharyngitis Drug Price by Application
5.3.1 Global Pharyngitis Drug Price by Application (2017-2022)
5.3.2 Global Pharyngitis Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pharyngitis Drug Market Size by Type
6.1.1 North America Pharyngitis Drug Sales by Type (2017-2028)
6.1.2 North America Pharyngitis Drug Revenue by Type (2017-2028)
6.2 North America Pharyngitis Drug Market Size by Application
6.2.1 North America Pharyngitis Drug Sales by Application (2017-2028)
6.2.2 North America Pharyngitis Drug Revenue by Application (2017-2028)
6.3 North America Pharyngitis Drug Market Size by Country
6.3.1 North America Pharyngitis Drug Sales by Country (2017-2028)
6.3.2 North America Pharyngitis Drug Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pharyngitis Drug Market Size by Type
7.1.1 Europe Pharyngitis Drug Sales by Type (2017-2028)
7.1.2 Europe Pharyngitis Drug Revenue by Type (2017-2028)
7.2 Europe Pharyngitis Drug Market Size by Application
7.2.1 Europe Pharyngitis Drug Sales by Application (2017-2028)
7.2.2 Europe Pharyngitis Drug Revenue by Application (2017-2028)
7.3 Europe Pharyngitis Drug Market Size by Country
7.3.1 Europe Pharyngitis Drug Sales by Country (2017-2028)
7.3.2 Europe Pharyngitis Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pharyngitis Drug Market Size by Type
8.1.1 Asia Pacific Pharyngitis Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Pharyngitis Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Pharyngitis Drug Market Size by Application
8.2.1 Asia Pacific Pharyngitis Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Pharyngitis Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Pharyngitis Drug Market Size by Region
8.3.1 Asia Pacific Pharyngitis Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Pharyngitis Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pharyngitis Drug Market Size by Type
9.1.1 Latin America Pharyngitis Drug Sales by Type (2017-2028)
9.1.2 Latin America Pharyngitis Drug Revenue by Type (2017-2028)
9.2 Latin America Pharyngitis Drug Market Size by Application
9.2.1 Latin America Pharyngitis Drug Sales by Application (2017-2028)
9.2.2 Latin America Pharyngitis Drug Revenue by Application (2017-2028)
9.3 Latin America Pharyngitis Drug Market Size by Country
9.3.1 Latin America Pharyngitis Drug Sales by Country (2017-2028)
9.3.2 Latin America Pharyngitis Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pharyngitis Drug Market Size by Type
10.1.1 Middle East and Africa Pharyngitis Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pharyngitis Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Pharyngitis Drug Market Size by Application
10.2.1 Middle East and Africa Pharyngitis Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pharyngitis Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Pharyngitis Drug Market Size by Country
10.3.1 Middle East and Africa Pharyngitis Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pharyngitis Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Genentech Inc
11.1.1 Genentech Inc Corporation Information
11.1.2 Genentech Inc Overview
11.1.3 Genentech Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Genentech Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Genentech Inc Recent Developments
11.2 Adamas Pharmaceutical Inc
11.2.1 Adamas Pharmaceutical Inc Corporation Information
11.2.2 Adamas Pharmaceutical Inc Overview
11.2.3 Adamas Pharmaceutical Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Adamas Pharmaceutical Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Adamas Pharmaceutical Inc Recent Developments
11.3 PLIVA HRVATSKA d.o.o
11.3.1 PLIVA HRVATSKA d.o.o Corporation Information
11.3.2 PLIVA HRVATSKA d.o.o Overview
11.3.3 PLIVA HRVATSKA d.o.o Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 PLIVA HRVATSKA d.o.o Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 PLIVA HRVATSKA d.o.o Recent Developments
11.4 Pfizer Inc
11.4.1 Pfizer Inc Corporation Information
11.4.2 Pfizer Inc Overview
11.4.3 Pfizer Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Inc Recent Developments
11.5 Valeant Pharmaceuticals International, Inc
11.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
11.5.2 Valeant Pharmaceuticals International, Inc Overview
11.5.3 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valeant Pharmaceuticals International, Inc Recent Developments
11.6 Mylan N.V
11.6.1 Mylan N.V Corporation Information
11.6.2 Mylan N.V Overview
11.6.3 Mylan N.V Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mylan N.V Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mylan N.V Recent Developments
11.7 GSK group of companies
11.7.1 GSK group of companies Corporation Information
11.7.2 GSK group of companies Overview
11.7.3 GSK group of companies Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GSK group of companies Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GSK group of companies Recent Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
11.8.2 Teva Pharmaceutical Industries Ltd Overview
11.8.3 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.9 AbbVie Inc
11.9.1 AbbVie Inc Corporation Information
11.9.2 AbbVie Inc Overview
11.9.3 AbbVie Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AbbVie Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AbbVie Inc Recent Developments
11.10 Viatris Inc. (Mylan)
11.10.1 Viatris Inc. (Mylan) Corporation Information
11.10.2 Viatris Inc. (Mylan) Overview
11.10.3 Viatris Inc. (Mylan) Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Viatris Inc. (Mylan) Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Viatris Inc. (Mylan) Recent Developments
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Corporation Information
11.11.2 GlaxoSmithKline plc Overview
11.11.3 GlaxoSmithKline plc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GlaxoSmithKline plc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline plc Recent Developments
11.12 Abbott Laboratories
11.12.1 Abbott Laboratories Corporation Information
11.12.2 Abbott Laboratories Overview
11.12.3 Abbott Laboratories Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Abbott Laboratories Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abbott Laboratories Recent Developments
11.13 Amgen Inc
11.13.1 Amgen Inc Corporation Information
11.13.2 Amgen Inc Overview
11.13.3 Amgen Inc Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Amgen Inc Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Amgen Inc Recent Developments
11.14 Sanofi-aventis Groupe
11.14.1 Sanofi-aventis Groupe Corporation Information
11.14.2 Sanofi-aventis Groupe Overview
11.14.3 Sanofi-aventis Groupe Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sanofi-aventis Groupe Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sanofi-aventis Groupe Recent Developments
11.15 Purdue Pharma L.P
11.15.1 Purdue Pharma L.P Corporation Information
11.15.2 Purdue Pharma L.P Overview
11.15.3 Purdue Pharma L.P Pharyngitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Purdue Pharma L.P Pharyngitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Purdue Pharma L.P Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharyngitis Drug Industry Chain Analysis
12.2 Pharyngitis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharyngitis Drug Production Mode & Process
12.4 Pharyngitis Drug Sales and Marketing
12.4.1 Pharyngitis Drug Sales Channels
12.4.2 Pharyngitis Drug Distributors
12.5 Pharyngitis Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pharyngitis Drug Industry Trends
13.2 Pharyngitis Drug Market Drivers
13.3 Pharyngitis Drug Market Challenges
13.4 Pharyngitis Drug Market Restraints
14 Key Findings in The Global Pharyngitis Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer